Yiheng Capital
Latest statistics and disclosures from Yiheng Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are JD, BILI, NOAH, ALAB, AKRO, and represent 88.55% of Yiheng Capital Management's stock portfolio.
- Added to shares of these 7 stocks: AKRO (+$18M), SVCO, EDU, KYMR, ALAB, API, YSG.
- Started 3 new stock positions in KYMR, SVCO, API.
- Reduced shares in these 10 stocks: JD (-$1.1B), BILI (-$554M), SMCI (-$27M), TAL (-$25M), HTHT (-$25M), RBLX (-$17M), MBLY (-$15M), ACMR (-$9.3M), BEAM (-$7.0M), VRDN.
- Sold out of its positions in MBLY, SMCI.
- Yiheng Capital Management was a net seller of stock by $-1.8B.
- Yiheng Capital Management has $1.1B in assets under management (AUM), dropping by -58.58%.
- Central Index Key (CIK): 0001447228
Tip: Access up to 7 years of quarterly data
Positions held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Yiheng Capital Management
Yiheng Capital Management holds 22 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Jd.com Spon Ads Cl A (JD) | 50.3 | $541M | -67% | 13M | 41.12 |
|
| Bilibili Spons Ads Rep Z (BILI) | 23.5 | $253M | -68% | 13M | 19.11 |
|
| Noah Hldgs Spon Ads (NOAH) | 5.9 | $64M | 6.7M | 9.45 |
|
|
| Astera Labs Put Option (ALAB) | 4.6 | $50M | +2% | 836k | 59.67 |
|
| Akero Therapeutics (AKRO) | 4.2 | $45M | +66% | 1.1M | 40.48 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 2.7 | $29M | +15% | 598k | 47.81 |
|
| H World Group Sponsored Ads (HTHT) | 2.2 | $24M | -50% | 646k | 37.01 |
|
| Roblox Corp Cl A (RBLX) | 1.5 | $17M | -50% | 282k | 58.29 |
|
| Atre Sponsored Ads (RERE) | 0.9 | $9.3M | 3.2M | 2.94 |
|
|
| Miragen Therapeutics (VRDN) | 0.6 | $6.7M | -33% | 500k | 13.48 |
|
| Acm Resh Com Cl A (ACMR) | 0.6 | $6.5M | -58% | 280k | 23.34 |
|
| Denali Therapeutics (DNLI) | 0.6 | $6.4M | -32% | 470k | 13.60 |
|
| Inventiva Sa Ads (IVA) | 0.5 | $5.7M | 2.6M | 2.14 |
|
|
| Silvaco Group (SVCO) | 0.4 | $4.6M | NEW | 1.0M | 4.56 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 0.4 | $4.5M | 656k | 6.82 |
|
|
| Tal Education Group Sponsored Ads (TAL) | 0.4 | $4.1M | -85% | 309k | 13.21 |
|
| Kymera Therapeutics (KYMR) | 0.3 | $3.4M | NEW | 123k | 27.37 |
|
| Beam Therapeutics (BEAM) | 0.1 | $1.3M | -83% | 69k | 19.53 |
|
| Agora Ads (API) | 0.1 | $774k | NEW | 193k | 4.02 |
|
| Yatsen Hldg Sponsored Ads (YSG) | 0.0 | $463k | +816% | 96k | 4.81 |
|
| Tuniu Corp Sponsored Ads (TOUR) | 0.0 | $346k | 314k | 1.10 |
|
|
| Generation Bio (GBIO) | 0.0 | $78k | 192k | 0.41 |
|
Past Filings by Yiheng Capital Management
SEC 13F filings are viewable for Yiheng Capital Management going back to 2015
- Yiheng Capital Management 2025 Q1 restated filed May 16, 2025
- Yiheng Capital Management 2024 Q4 filed Feb. 11, 2025
- Yiheng Capital Management 2024 Q3 filed Nov. 12, 2024
- Yiheng Capital Management 2024 Q2 filed Aug. 14, 2024
- Yiheng Capital Management 2024 Q1 filed May 15, 2024
- Yiheng Capital Management 2023 Q4 filed Feb. 14, 2024
- Yiheng Capital Management 2023 Q3 filed Nov. 14, 2023
- Yiheng Capital Management 2023 Q2 filed Aug. 14, 2023
- Yiheng Capital Management 2023 Q1 filed May 15, 2023
- Yiheng Capital Management 2022 Q4 filed Feb. 14, 2023
- Yiheng Capital Management 2022 Q3 filed Nov. 14, 2022
- Yiheng Capital Management 2022 Q2 filed Aug. 15, 2022
- Yiheng Capital Management 2022 Q1 filed May 16, 2022
- Yiheng Capital Management 2021 Q4 filed Feb. 14, 2022
- Yiheng Capital Management 2021 Q3 filed Nov. 15, 2021
- Yiheng Capital Management 2021 Q2 restated filed Sept. 21, 2021